5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.83▼ | 0.83▼ | 0.84▼ | 1.11▼ | 1.08▼ |
MA10 | 0.83▼ | 0.85▼ | 0.84▼ | 1.11▼ | 1.16▼ |
MA20 | 0.83▼ | 0.85▼ | 0.98▼ | 1.12▼ | 1.17▼ |
MA50 | 0.85▼ | 1.02▼ | 1.08▼ | 1.19▼ | 1.15▼ |
MA100 | 0.94▼ | 1.10▼ | 1.18▼ | 1.16▼ | 1.40▼ |
MA200 | 1.06▼ | 1.17▼ | 1.21▼ | 1.10▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.008▲ | -0.009▼ | -0.020▼ | -0.023▼ |
RSI | 28.156▼ | 30.655▼ | 30.362▼ | 31.245▼ | 38.151▼ |
STOCH | 20.058 | 11.149▼ | 13.694▼ | 62.983 | 16.419▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ |
CCI | -74.242 | -108.349▼ | -119.729▼ | -232.882▼ | -183.488▼ |
Thursday, May 16, 2024 05:14 AM
May 15, 2024Dole plc beats earnings expectations. Reported EPS is $0.43, expectations were $0.31. Operator: Welcome to the Dole Plc’s First Quarter 2024 Earnings Conference Call and Webcast. Today's ...
|
Wednesday, May 15, 2024 12:01 PM
Key updates include leadership changes, significant workforce reduction, and promising developments in cancer treatment trials.
|
Wednesday, May 15, 2024 10:38 AM
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday's session after the company reported first-quarter financial results. Bolt Biotherapeutics posted a GAAP loss of 28 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 0.8575 | 0.8749 | 0.8251 | 0.8251 | 570,209 |
15/05/24 | 1.02 | 1.04 | 0.8288 | 0.83 | 3,778,978 |
14/05/24 | 1.31 | 1.32 | 1.25 | 1.32 | 101,397 |
13/05/24 | 1.29 | 1.32 | 1.23 | 1.32 | 206,155 |
10/05/24 | 1.125 | 1.27 | 1.10 | 1.26 | 268,652 |
09/05/24 | 1.11 | 1.14 | 1.09 | 1.12 | 81,438 |
08/05/24 | 1.09 | 1.11 | 1.09 | 1.11 | 76,299 |
07/05/24 | 1.10 | 1.11 | 1.08 | 1.08 | 22,264 |
06/05/24 | 1.10 | 1.11 | 1.08 | 1.10 | 39,676 |
03/05/24 | 1.12 | 1.12 | 1.04 | 1.10 | 38,137 |
|
|
||||
|
|
||||
|
|